Stay updated on Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's release notes show a new revision label (v3.6.5) replacing the previous v3.6.4, indicating a minor update to the page/system rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-06T19:27:25.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision: v3.6.4 has been added and Revision: v3.6.3 removed, indicating a minor version update to the page's release notes/metadata. This update updates the version label on the page to reflect a new release and may accompany small UI or data adjustments.
    Difference
    0.0%
    Check dated 2026-07-23T10:25:15.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A new publication related to the study has been added to Publications (Telisotuzumab Vedotin in c-Met+ NSCLC), and the page shows a new revision (v3.6.3) with the older version (v3.6.1) removed, indicating an updated study record.
    Difference
    0.0%
    Check dated 2026-07-02T05:27:02.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.1, representing a minor publication release of the page. No content changes are indicated by the change data.
    Difference
    0.0%
    Check dated 2026-06-25T04:59:07.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Recruitment is now shown as closed for this study, and new navigation links for How to Read a Study Record, Common Questions, and How to Join a Study have been added. There are also minor formatting tweaks to the Intervention/Treatment heading and to the revision notes.
    Difference
    0.1%
    Check dated 2026-06-10T22:08:35.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Revision version updated from v3.5.4 to v3.5.5, reflecting a minor update to the page's revision tracking.
    Difference
    0.0%
    Check dated 2026-06-03T17:30:23.000Z thumbnail image

Stay in the know with updates to Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page.